Jan 09, 2023 15:00 JST

Source: Malaysian Genomics Resource Centre Bhd

Malaysian Genomics Explores R&D Collaboration with SIRIM
Group enters into strategic cooperation for projects in the medical and biotechnology fields

PETALING JAYA, Malaysia, Jan 09, 2023 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce a strategic cooperation with SIRIM Berhad, to explore the commercialisation of joint research and development (R&D) projects in the medical and biotechnology fields.

Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics
 


SIRIM Berhad is wholly owned by the Malaysian Government, and is focused on R&D, standardisation and quality. The organisation acts as a catalyst for industrial development through programmes involving technology and standardisation.

Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomics-driven biotechnology R&D projects. These include developing biofuels and biopharmaceuticals, companion diagnostic tests for cancer treatment, and bioactive cosmeceuticals.

Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics, said, "SIRIM and Malaysian Genomics have complementary experiences, resources, and technology assets. Teams from both organisations have met to explore their research and develop interests in precision medicine, food security, and products for the consumer market. This strategic collaboration will pave the way for individual agreements specific to projects for which commercial opportunities have been identified."

President and Group Chief Executive Officer of SIRIM Berhad, Dato' Indera Dr Ahmad Sabirin Arshad said, "We look forward to working closely with Malaysian Genomics on R&D projects that can benefit the country and domestic industries. This strategic collaboration will expedite the relevant processes to ensure that both parties can explore the commercial viability of projects, before commencing research, development and commercialisation."

The parties of this two-year strategic collaboration will also jointly source for suitable private and public institutional partners for the funding and commercialisation of these projects.

Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

Source: Malaysian Genomics Resource Centre Bhd
Sectors: Daily Finance, Daily News, BioTech, Healthcare & Pharm, Local Biz

Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Related Press Release


Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
August 29 2023 13:00 JST
 
Malaysian Genomics Inks Agreement in Expansion to Bangladesh
May 15 2023 18:00 JST
 
Malaysian Genomics to Boost Play on the Football Pitch
February 27 2023 13:00 JST
 
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
February 24 2023 17:30 JST
 
Malaysian Genomics to Collaborate on Cannabinoid R&D
February 24 2023 13:30 JST
 
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
February 22 2023 14:30 JST
 
Malaysian Genomics Sees Rise in Profit Margins for 1Q
November 23 2022 17:30 JST
 
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
October 26 2022 19:00 JST
 
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities
October 12 2022 13:00 JST
 
Malaysian Genomics Grows Presence in Thailand
September 23 2022 14:00 JST
 
More Press release >>

Latest Press Release


More Latest Release >>